Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | BCL2L1 | Q07817 | 3/20 | 0.30 |
| ▸ | BAK1 | Q16611 | 3/20 | 0.30 |
| ▸ | USP2 | O75604 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | APAF1 | O14727 | 1/20 | 0.30 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1898549 | 0.84 | — | — | |
| Fluoride SCHEMBL27504066 | 0.82 | TSHR (0.34) | TSHRALDH1A1SMN1; SMN2OPRM1 | |
| SCHEMBL25270659 | 0.81 | CYP3A4 (0.44) | TSHRALDH1A1TDP1CYP3A4CA2 | |
| SCHEMBL942299 | 0.76 | FAAH (0.40) | TSHRALDH1A1OPRM1 | |
| SCHEMBL27781459 | 0.76 | FAAH (0.40) | TSHRALDH1A1OPRM1 | |
| SCHEMBL4210767 | 0.76 | FAAH (0.40) | TSHRALDH1A1OPRM1 | |
| SCHEMBL8418571 | 0.76 | FAAH (0.40) | TSHRALDH1A1OPRM1 | |
| SCHEMBL19113967 | 0.75 | — | — | |
| SCHEMBL4604387 | 0.75 | — | — | |
| SCHEMBL6854262 | 0.75 | TSHR (0.60) | TSHRALDH1A1TDP1CYP3A4CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2816065-B1 | METHOD FOR PRODUCING HOMOPOLYMER OR RANDOM COPOLYMER OF HYDROXYL GROUP-CONTAINING VINYL ETHER | MARUZEN PETROCHEM CO LTD (JP) | 2018-01-31 | — | — | EP | disclosed |
| US-9777085-B2 | Method for producing homopolymer or random copolymer of hydroxyl group-containing vinyl ether | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20150011513-A1 | ALKYNE-, AZIDE- AND TRIAZOLE-CONTAINING FLAVONOIDS AS MODULATORS FOR MULTIDRUG RESISTANCE IN CANCERS | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2015-01-08 | — | — | US | disclosed |
| US-20150005467-A1 | METHOD FOR PRODUCING HOMOPOLYMER OR RANDOM COPOLYMER OF HYDROXYL GROUP-CONTAINING VINYL ETHER | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2015-01-01 | — | — | US | disclosed |
| EP-2816065-A1 | METHOD FOR PRODUCING HOMOPOLYMER OR RANDOM COPOLYMER OF HYDROXYL GROUP-CONTAINING VINYL ETHER | Maruzen Petrochemical Co., Ltd. (JP) | 2014-12-24 | — | — | EP | disclosed |
| US-5770655-A | ACRYLATE MONOMER WITH MULTICYCLIC FUSED RING IN ESTER GROUP, OPTICAL FIBERS AND DISKS, CLARITY AND IMPACT STRENGTH, TETRACYCLODODECYL ACRYLATE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1998-06-23 | — | — | US | disclosed |
| EP-0671433-B1 | Polymer composition and core-shell elastomer used therefor | MITSUI CHEMICALS INC (JP) | 1998-06-17 | — | — | EP | disclosed |
| US-5574100-A | ALPHA-OLEFIN-CYCLIC OLEFIN COPOLYMER, BUTADIENE-STYRENE COPOLYMER CORE, ALICYCLIC ACRYLATE SHELL | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1996-11-12 | — | — | US | disclosed |
| EP-0671433-A1 | Polymer composition and core-shell elastomer used therefor | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1995-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011513-A1 | ALKYNE-, AZIDE- AND TRIAZOLE-CONTAINING FLAVONOIDS AS MODULATORS FOR MULTIDRUG RESISTANCE IN CANCERS | ABCG2, ABCB1, ABCC1 | TSHR 1013/4885ALDH1A1 2738/4885TDP1 915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.